We are live on ! Find out more
GDRX icon

GoodRx Holdings

170 hedge funds and large institutions have $633M invested in GoodRx Holdings in 2024 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

253% more call options, than puts

Call options by funds: $4.22M | Put options by funds: $1.2M

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

31% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 35

13% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 47

1% more funds holding

Funds holding: 168170 (+2)

13.83% less ownership

Funds ownership: 144.32%130.49% (-14%)

36% less capital invested

Capital invested by funds: $988M → $633M (-$355M)

Holders
170
Holders Change
+2
Holders Change %
+1.19%
% of All Funds
2.24%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
53
Increased
46
Reduced
35
Closed
47
Calls
$4.22M
Puts
$1.2M
Net Calls
+$3.02M
Net Calls Change
+$930K

GDRX Hedge Fund Activity: Q4 2024 in Review

170 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q4 2024, worth a combined $633M — down 36% from $988M a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new GDRX positions and 47 closed out — a net gain of 6 holders — while 46 added to existing stakes and 35 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $6.93M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $26.5M sold.

  • 170 institutional investors held GoodRx Holdings (GDRX) as of Q4 2024, up from 168 in Q3 2024.
  • Funds reported $633M of GoodRx Holdings stock for Q4 2024, down 36% quarter-over-quarter.
  • 53 funds opened new GoodRx Holdings positions in Q4 2024 and 47 closed out, a net change of +6 holders.
  • The largest GoodRx Holdings buyer in Q4 2024 was ClearBridge Investments, an estimated $6.93M added.
  • The largest GoodRx Holdings seller in Q4 2024 was T. Rowe Price Investment Management, an estimated $26.5M sold.

Based on aggregated 13F filings for Q4 2024.